Shilpa Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 1.84 Cr
- Company Age 20 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 37.96 Cr
- Revenue Growth -34.47%
- Profit Growth 0.85%
- Ebitda 13.73%
- Net Worth -32.26%
- Total Assets -0.65%
About Shilpa Therapeutics
Shilpa Therapeutics Private Limited (STPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 April 2004 and has a history of 20 years and ten months. Its registered office is in Raichur, Karnataka, India.
The Corporate was formerly known as Nu Therapeutics Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.84 Cr.
The company has closed loans amounting to ₹37.96 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Vishnukanth Bhutada and Ramakant Innani serve as directors at the Company.
Company Details
-
Location
Raichur, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239KA2004PTC176079
-
Company No.
043005
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Apr 2004
-
Date of AGM
16 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Shilpa Therapeutics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishnukanth Bhutada
|
Nominee Director | 07-Sep-2011 | Current |
|
Ramakant Innani
|
Director | 07-Sep-2011 | Current |
Financial Performance of Shilpa Therapeutics.
Shilpa Therapeutics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 34.47% decrease. The company also saw a slight improvement in profitability, with a 0.85% increase in profit. The company's net worth observed a substantial decline by a decrease of 32.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shilpa Therapeutics?
Unlock access to Shilpa Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Sravathi Advance Process Technologies Private LimitedVishnukanth Bhutada and Ramakant Innani are mutual person
-
Inm Technologies Private LimitedVishnukanth Bhutada and Ramakant Innani are mutual person
-
Inm Nuvent Paints Private LimitedVishnukanth Bhutada and Ramakant Innani are mutual person
-
Shilpa Biologicals Private LimitedVishnukanth Bhutada and Ramakant Innani are mutual person
-
Ftf Pharma Private LimitedVishnukanth Bhutada is a mutual person
-
Shilpa Medicare LimitedVishnukanth Bhutada is a mutual person
Charges (Loans)
₹0
₹37.96 Cr
Charges Breakdown by Lending Institutions
- Citi Bank N.A. : 30.00 Cr
- Bank Of Baroda : 4.00 Cr
- Axis Bank Limited : 2.00 Cr
- Andhra Bank : 1.96 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Apr 2020 | Citi Bank N.A. | ₹25.00 Cr | Satisfied |
| 16 Apr 2020 | Citi Bank N.A. | ₹5.00 Cr | Satisfied |
| 19 Dec 2016 | Axis Bank Limited | ₹2.00 Cr | Satisfied |
| 19 Dec 2007 | Bank Of Baroda | ₹4.00 Cr | Satisfied |
| 26 May 2007 | Andhra Bank | ₹7.00 M | Satisfied |
How Many Employees Work at Shilpa Therapeutics?
Shilpa Therapeutics has a workforce of 24 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shilpa Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shilpa Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
